A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

Acquired chemotherapy resistance is a major contributor to treatment failure in oncology. For example, the efficacy of the common anticancer agent doxorubicin (DOX) is limited by the emergence of multidrug resistance (MDR) phenotype in cancer cells. While dose escalation of DOX can circumvent such r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pramanik, Dipankar, Campbell, Nathaniel R., Das, Samarjit, Gupta, Sonal, Chenna, Venugopal, Bisht, Savita, Sysa-Shah, Polina, Bedja, Djahida, Karikari, Collins, Steenbergen, Charles, Gabrielson, Kathleen L., Maitra, Amarnath, Maitra, Anirban
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2012
Konular:
Research Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3442295/
https://ncbi.nlm.nih.gov/pubmed/22791660
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller